Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (181-190 of 369) with videos related to

Pageof 37
Sort By:
Plos Medicine|August 6, 2011
Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyStephen D Lawn, Sophie V Brooks, Katharina Kranzer, et al.
Journal of Adolescence|December 26, 2006
Brief report: methods for collecting sexual behaviour information from South African adolescents--a comparison of paper versus personal digital assistant questionnairesHeather B Jaspan, Alan J Flisher, Landon Myer, et al.
Social Science & Medicine (1982)|May 31, 2016
Forced removals embodied as tuberculosisEugene T Richardson, Carl D Morrow, Theodore Ho, et al.
Infection Control and Hospital Epidemiology|July 27, 2022
Environmental air sampling for detection and quantification of <i>Mycobacterium tuberculosis</i> in clinical settings: Proof of conceptKeren Middelkoop, Anastasia S Koch, Zeenat Hoosen, et al.
The Journal of Infectious Diseases|December 6, 2013
The survival benefits of antiretroviral therapy in South AfricaMichael D April, Robin Wood, Bethany K Berkowitz, et al.
Plos One|December 11, 2013
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trialPrudence Ive, William MacLeod, Nompumelelo Mkumla, et al.
International Journal of Epidemiology|March 11, 2014
Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened communityKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Plos Medicine|July 11, 2008
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedOlivia Keiser, Catherine Orrell, Matthias Egger, et al.
Plos One|November 25, 2011
Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methodsKatharina Kranzer, James J Lewis, Richard G White, et al.
Clinical Therapeutics|July 25, 2006
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on studyJoseph C Gathe, Robin Wood, Ian Sanne, et al.
Pageof 37

Showing results (181-190 of 369) with videos related to

Sort By:
Pageof 37
Plos Medicine|August 6, 2011
Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyStephen D Lawn, Sophie V Brooks, Katharina Kranzer, et al.
Journal of Adolescence|December 26, 2006
Brief report: methods for collecting sexual behaviour information from South African adolescents--a comparison of paper versus personal digital assistant questionnairesHeather B Jaspan, Alan J Flisher, Landon Myer, et al.
Social Science & Medicine (1982)|May 31, 2016
Forced removals embodied as tuberculosisEugene T Richardson, Carl D Morrow, Theodore Ho, et al.
Infection Control and Hospital Epidemiology|July 27, 2022
Environmental air sampling for detection and quantification of <i>Mycobacterium tuberculosis</i> in clinical settings: Proof of conceptKeren Middelkoop, Anastasia S Koch, Zeenat Hoosen, et al.
The Journal of Infectious Diseases|December 6, 2013
The survival benefits of antiretroviral therapy in South AfricaMichael D April, Robin Wood, Bethany K Berkowitz, et al.
Plos One|December 11, 2013
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trialPrudence Ive, William MacLeod, Nompumelelo Mkumla, et al.
International Journal of Epidemiology|March 11, 2014
Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened communityKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Plos Medicine|July 11, 2008
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedOlivia Keiser, Catherine Orrell, Matthias Egger, et al.
Plos One|November 25, 2011
Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methodsKatharina Kranzer, James J Lewis, Richard G White, et al.
Clinical Therapeutics|July 25, 2006
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on studyJoseph C Gathe, Robin Wood, Ian Sanne, et al.
Pageof 37